Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure

Fig. 1

Experimental protocol. Pregnant female mice received a single oral dose of 800 mg/kg sodium valproate on E11.5. Minocycline (100 mg/kg/day) or maraviroc (80 mg/kg/day) was dissolved in drinking water and administered to dams from P1 to P21. Behavioral tests were performed in the order of open field test, Y-maze test, social affiliation test and marble burying test from the age of 6 weeks

Back to article page